Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study (Q68414515)
Jump to navigation
Jump to search
scientific article published on 01 February 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study |
scientific article published on 01 February 1990 |
Statements
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study (English)
G Blackledge
A van Oosterom
H Mouridsen
W P Steward
J Buesa
D Thomas
R Sylvester
1 February 1990